mcas and glutathione MTHFR LC, CFS, POTS, MCAS, SIBO, EDS: Methylating the Alphabet - Article (Preprint v1) by Patrick Chambers An Open-Label Case Series of

If a dose is missed, the patient should follow their physicians guidance

benefit: FDA only looked at risk, ignored benefits Off-label use: Doctors prescribe drugs off-label all the time Patient access: People are suffering and need options Regulatory capture: Big Pharma doesn't want cheap peptides competing The problem with these arguments: It's NOT off-label use Off-label only applies to FDA-approved drugs

Sermorelin: a review of its use in diagnosing and treating children with idiopathic growth hormone deficiency

An initial challenge of 10 M phenylephrine (PE), followed by 10 M acetylcholine (ACh) was used to assess the condition of the artery